| 标题 |
The Totality of Evidence and Use of ABP 215, a Biosimilar to Bevacizumab |
| 网址 | |
| DOI | |
| 其它 | DOI: 10.1007/s40487-020-00133-1; PMID: 33336310; Journal: Oncology and therapy; Year: 2021 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)